You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 142 No. 7, July 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (3)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Dermatologic Disorders
 •Psoriasis
 •Dermatologic Procedures
 •Phototherapy
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

COMMENTS AND OPINIONS
Targeted UV-B Phototherapy: When and Why to Start

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

We read with interest the article by Asawanonda and colleagues1 on the use of targeted UV-B phototherapy for plaque-type psoriasis, in which the authors describe results reported by our research team in a study dealing with similar treatments.2 We totally agree that targeted UV-B phototherapy is safe and convenient for the treatment of some skin disorders, including localized and recalcitrant psoriasis in plaques.

However, the assumption of the authors1 that we used the 308-nm excimer laser is incorrect. In fact we treated our patients with a 308-nm monochromatic excimer light, which was not generated by a laser but by a device releasing a noncoherent light.2

In addition, Asawanonda et al1 speculate that, because UV-B radiation penetrates rather superficially into the dermis, it might be of limited use in palmoplantar psoriasis. This has not been the case with our patients. Instead, we have seen that palmoplantar psoriasis is the form that . . . [Full Text of this Article]


AUTHOR INFORMATION
Torello Lotti, MD; Riccardo Rossi, MD; Piero Campolmi, MD



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Targeted UV-B Phototherapy: When and Why to Start—Reply
Pravit Asawanonda, Akrawat Chingchai, and Pawinee Torranin
Arch Dermatol. 2006;142(7):934.
EXTRACT | FULL TEXT  

Targeted UV-B Phototherapy for Plaque-type Psoriasis
Pravit Asawanonda, Akkrawat Chingchai, and Pawinee Torranin
Arch Dermatol. 2005;141(12):1542-1546.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.